Amgen Inc. is emphasizing its comprehensive approach to cancer, but the groundwork the firm has laid in immunotherapy might be what helps the franchise move forward.
During a June 1 briefing at the American Society of Clinical Oncology annual meeting in Chicago, Amgen noted that its...